Scholarlink

Purpose <p>Dopamine D<sub>2/3</sub> receptors are expressed throughout the human brain, but synchronous receptor quantification in subcortical and cortical brain areas remains difficult to achieve with a single radioligand. Here, we assessed the suitability of a bolus plus constant infusion (B/I) paradigm for brain-wide dopamine D<sub>2/3</sub> receptor imaging with the agonist radioligand [<sup>11</sup>C]-(+)-PHNO.</p> Methods <p>Five healthy male volunteers underwent two B/I [<sup>11</sup>C]-(+)-PHNO positron emission tomography (PET) scans combined with a mid-scan intravenous amphetamine challenge. Non-displaceable binding potentials (BP<sub>ND</sub>) were calculated using the equilibrium ratio method and an algorithmically constrained cerebellum as the reference region.</p> Results <p>Reproducible baseline BP<sub>ND</sub> values were obtained for the majority of regions examined, with intraclass correlation coefficients ranging from 0.5 to 0.93, and test-retest variability remaining below 10%. Moreover, amphetamine-induced decreases in receptor binding were observed in both scans in cortical and a number of subcortical regions. In the globus pallidus and ventral striatum, however, equilibrium had not been reached prior to amphetamine injection, suggesting that further optimization of the protocol might be needed to quantify amphetamine effects in D<sub>3</sub> receptor-rich regions.</p> Conclusions <p>These results indicate that, within certain limitations, synchronous cortical and subcortical measurements of D<sub>2/3</sub> receptors at baseline and under challenge conditions can be achieved using the B/I approach and [<sup>11</sup>C]-(+)-PHNO PET.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Continuous infusion [11C]-(+)-PHNO PET for measuring dopamine D2/3 receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月15日

查看全文
  • Irena Dajic,
  • Ulrich Sauerzopf,
  • Ana Weidenauer,
  • Cornelia Diendorfer,
  • Katharina Landesmann,
  • Ivo Rausch,
  • Andreas Hahn,
  • Benjamin Spurny-Dworak,
  • Manfred Klöbl,
  • Murray Reed,
  • Rupert Lanzenberger,
  • Martin Bauer,
  • Markus Zeitlinger,
  • Lucie Bartova,
  • Martin Wolkersdorfer,
  • Lukas Nics,
  • Wolfgang Wadsak,
  • Marcus Hacker,
  • Cécile Philippe,
  • Nicole Praschak-Rieder,
  • Matthäus Willeit

摘要

Purpose

Dopamine D2/3 receptors are expressed throughout the human brain, but synchronous receptor quantification in subcortical and cortical brain areas remains difficult to achieve with a single radioligand. Here, we assessed the suitability of a bolus plus constant infusion (B/I) paradigm for brain-wide dopamine D2/3 receptor imaging with the agonist radioligand [11C]-(+)-PHNO.

Methods

Five healthy male volunteers underwent two B/I [11C]-(+)-PHNO positron emission tomography (PET) scans combined with a mid-scan intravenous amphetamine challenge. Non-displaceable binding potentials (BPND) were calculated using the equilibrium ratio method and an algorithmically constrained cerebellum as the reference region.

Results

Reproducible baseline BPND values were obtained for the majority of regions examined, with intraclass correlation coefficients ranging from 0.5 to 0.93, and test-retest variability remaining below 10%. Moreover, amphetamine-induced decreases in receptor binding were observed in both scans in cortical and a number of subcortical regions. In the globus pallidus and ventral striatum, however, equilibrium had not been reached prior to amphetamine injection, suggesting that further optimization of the protocol might be needed to quantify amphetamine effects in D3 receptor-rich regions.

Conclusions

These results indicate that, within certain limitations, synchronous cortical and subcortical measurements of D2/3 receptors at baseline and under challenge conditions can be achieved using the B/I approach and [11C]-(+)-PHNO PET.